Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chuangjie Zheng
Observed name:
Zheng, Chuangjie
Institution:
Guangzhou University of Chinese Medicine
Observed institutions:
Guangzhou University of Chinese Medicine,
First Affiliated Hospital of Guangzhou University of Chinese Medicine,
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
ORCID:
0000-0001-7488-1363
Observed ORCID:
0000-0001-7488-1363
OpenAlex ID:
A5070921257
First-line treatments for patients with advanced ALK gene rearrangements in NSCLC: a systematic review and network meta-analysis
2022
·
Jiahao Tao
, Chuangjie Zheng
, et al.
·
Journal of International Medical Research
·
9
MYC-dependent MiR-7-5p regulated apoptosis and autophagy in diffuse large B cell lymphoma by targeting AMBRA1
2024
·
Cuifen Zhang
, Ke Wang
, et al.
·
Molecular and Cellular Biochemistry
·
6
PDF
Safety and efficacy of rechallenge with immune checkpoint inhibitors and anlotinib in advanced non-small cell lung cancer without targetable driver mutations: a retrospective analysis
2025
·
Xinrong Chen
, Ke Wang
, et al.
·
BMC Cancer
·
5
PDF
Age-related differences in primary central nervous system lymphomas based on the SEER database
2025
·
Ke Wang
, Chuangjie Zheng
, et al.
·
Frontiers in Medicine
·
5
PDF
Updated Bayesian network meta-analysis on the efficacy and safety of PD−1 versus PD−L1 inhibitors in first−line treatment with chemotherapy for extensive−stage small-cell lung cancer
2025
·
Ke Wang
, Chuangjie Zheng
, et al.
·
Frontiers in Oncology
·
3
PDF
Yifei Sanjie pill combined with gefitinib reduces the progression of EGFR-TKIs-resistant non-small cell lung cancer via YAP/ANKRD1 axis
2026
·
Yi Yuan
, Ruisheng Zhou
, et al.
·
Phytomedicine
·
2
Onychopathy Following Durvalumab Treatment for Extensive-Stage Small-Cell Lung Cancer: A Case Report
2023
·
Cuifen Zhang
, Ke Wang
, et al.
·
Clinical Cosmetic and Investigational Dermatology
·
2
PDF
Comparison and Analysis of the Drug‐Resistance Mechanism of Osimertinib‐ and Almonertinib‐Resistant Cell Lines
2025
·
Chuangjie Zheng
, Yingfang Ren
, et al.
·
Analytical Cellular Pathology
·
1
Early modulation of pituitary gonadotropins during PD-1 inhibitor–based immunochemotherapy in patients with solid tumors
2026
·
Deyu Yang
, Xinrong Chen
, et al.
·
Research Square
PDF
Comparison of bevacizumab and immune checkpoint inhibitors combined with chemotherapy in the first-line treatment of advanced non-squamous non-small cell lung cancer: a systematic review and network meta-analysis
2021
·
Jiahao Tao
, Ling Zhou
, et al.
PDF
Efficacy and safety of first-line treatments for patients with advanced anaplastic lymphoma kinase gene rearrangements in non-small cell lung cancer: a systematic review and network meta-analysis
2021
·
Jiahao Tao
, Cuifen Zhang
, et al.
PDF
Show more works
View as search
Works count:
14
Citation count:
33
H-index:
4
I10-index:
Year
Topic
Type